Screening for Spinal Muscular Atrophy Not Cost-Effective: Study (HealthDay)
HealthDay – FRIDAY, Feb. 5 (HealthDay News) — It’s not cost-effective to
screen couples genetically to determine if they’re at risk of having
children with spinal muscular atrophy (SMA), says a U. S. study.
View full post on Yahoo! News: Health News
Leave a Reply